scholarly journals Effect of a caspase inhibitor, zVADfmk, on the inhibition of breast cancer cells by herpes simplex virus type 1

2011 ◽  
Vol 18 (10) ◽  
pp. 685-694 ◽  
Author(s):  
L W Wood ◽  
E J Shillitoe
2010 ◽  
Vol 60 (4) ◽  
pp. 407-413
Author(s):  
Septimiu Bucurescu

Development of a selective biopharmaceutical from Herpes simplex virus type 1 glycoproteins E and I for blocking antibody mediated neutralization of oncolytic virusesFuture cancer therapies will be molecular cures. They will correct, block or destroy cancer cells by targeting molecular changes that lead to carcinogenesis. Destroying cancer cells can be done using oncolytic viruses. By blocking antibody mediated neutralization of oncolytic viruses, Herpes simplex virus type 1 glycoproteins E and I could be used in the adjuvant treatment of cancer for improving the chances of oncolytic viruses to kill cancer cells in vivo.


2003 ◽  
Vol 85 (1) ◽  
pp. 42-47 ◽  
Author(s):  
Osamu Teshigahara ◽  
Fumi Goshima ◽  
Kazumasa Takao ◽  
Shin-ichi Kohno ◽  
Hideto Kimata ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A136-A137
Author(s):  
K TSAMAKIDES ◽  
E PANOTOPOULOU ◽  
D DIMITROULOPOULOS ◽  
M CHRISTOPOULO ◽  
D XINOPOULOS ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document